Volume 2, Issue 2 gathers seven articles spanning ophthalmology, immunology, dermatology and vascular biology. It reviews low-level laser therapy in ophthalmology and precision astigmatism correction via femtosecond laser in cataract surgery. The issue then explores immune-balance targets for biologics in inflammatory bowel disease and clarifies myths versus realities in beta-lactam allergy. Nanomedicine advances are highlighted through polymer nanoparticles for cancer immunotherapy, while a novel scalp coverage scoring method offers a segmental approach to hair density assessment. Finally, microRNA therapies for peripheral arterial disease are presented as an emerging frontier. Together, the articles reflect the journal's mission of linking molecular discovery with clinical practice.